ECLEcolab Inc. presents a strong fundamental profile driven by its essential services in water, hygiene, and infection prevention, supported by consistent profitability and a stable business model. Thematic tailwinds related to global health and sustainability are positive. Technical indicators are mixed, suggesting some short-term caution but an overall positive long-term trend.
Ecolab is well-positioned to benefit from global trends in water scarcity, hygiene awareness, and infection control, which are secular growth drivers for its business. Increasing focus on ESG also aligns with its core offerings.
Ecolab demonstrates strong financial health with consistent revenue growth, robust profitability, and a healthy balance sheet. Its ability to generate significant free cash flow supports its operations and shareholder returns.
Ecolab's stock is trading above key moving averages, indicating a generally positive trend. However, some short-term indicators suggest potential for consolidation or minor pullbacks.
| Factor | Score |
|---|---|
| Water Scarcity & Management | 90 |
| Hygiene & Infection Prevention | 88 |
| ESG & Sustainability Focus | 85 |
| Industrial Sector Growth | 70 |
| Regulatory Environment | 80 |
| Factor | Score |
|---|---|
| Valuation | 60 |
| Profitability | 85 |
| Growth | 70 |
| Balance Sheet Health | 75 |
| Cash Flow | 88 |
| Factor | Score |
|---|---|
| Trend Analysis | 80 |
| Momentum | 70 |
| Support & Resistance | 75 |
| Volume | 70 |
Consistent EPS Growth
The company has consistently beaten earnings estimates for the past five quarters, with an average surprise of 1.38%. Recent EPS for 2024Q1 was $1.55 against an estimate of $1.54.
Strong Current Ratio
The current ratio of 1.25 (Current Assets $22.37B / Current Liabilities $17.91B based on Q4 2024 data) indicates a healthy ability to meet short-term obligations.
High Price-to-Sales Ratio
The Price/Sales (P/S) ratio of 6.5 (TTM) is relatively high, suggesting that the market may be placing a premium on the company's revenue, which could lead to a valuation correction if growth falters.
Recent Margin Compression
Net margin for 2024Q4 was 11.8%, a slight decrease from 13.4% in 2024Q4 (though there was an improvement from 9.0% in 2023Q4). Continued margin pressure could impact profitability.
June 2025
17
Ex-Dividend Date
July 2025
15
Next Dividend Date
July 2025
29
Next Earnings Date
H: $1.94
A: $1.90
L: $1.86
H: 4.08B
A: 4.03B
L: 3.97B
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four reportable segments: Global Industrial, Global Institutional & Specialty, Global Healthcare & Life Sciences, and Global Pest Elimination. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, refining, pulp and paper, and petrochemical industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. The Global Healthcare & Life Sciences segment offers cleaning and sanitizing products, such as infection prevention, and end-to-end cleaning and contamination control solutions to the healthcare, personal care, and pharmaceutical industries under the Ecolab, Bioquell, Purolite, and Anios brand names. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. It sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
276.21 USD
The 39 analysts offering 1 year price forecasts for ECL have a max estimate of 320.00 and a min estimate of 230.00.